The opposing effects of n-3 and n-6 fatty acids

被引:899
|
作者
Schmitz, Gerd [1 ]
Ecker, Josef [1 ]
机构
[1] Univ Regensburg, Inst Clin Chem, D-93042 Regensburg, Germany
关键词
arachidonic acid; docosahexaenoic acid; eicosanoids; eicosapentaenoic acid; gene expression; inflammation; lipid metabolism; n-3; n-6;
D O I
10.1016/j.plipres.2007.12.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polyunsaturated fatty acids (PUFAs) can be classified in n-3 fatty acids and n-6 fatty acids, and in westernized diet the predominant dietary PUFAs are n-6 fatty acids. Both types of fatty acids are precursors of signaling molecules with opposing effects, that modulate membrane microdomain composition, receptor signaling and gene expression. The predominant n-6 fatty acid is arachidonic acid, which is converted to prostaglandins, leukotrienes and other lipoxygenase or cyclooxygenase products. These products are important regulators of cellular functions with inflammatory, atherogenic and prothrombotic effects. Typical n-3 fatty acids are docosahexaenoic acid and eicosapentaenoic acid, which are competitive substrates for the enzymes and products of arachidonic acid metabolism. Docosahexaenoic acid- and eicosapentaenoic acid-derived eicosanoids antagonize the pro-inflammatory effects of n-6 fatty acids. n-3 and n-6 fatty acids are ligands/modulators for the nuclear receptors NF kappa B, PPAR and SREBP-1c, which control various genes of inflammatory signaling and lipid metabolism. n-3 Fatty acids down-regulate inflammatory genes and lipid synthesis, and stimulate fatty acid degradation. In addition, the n-3/n-6 PUFA content of cell and organelle membranes, as well as membrane microdomains strongly influences membrane function and numerous cellular processes such as cell death and survival. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:147 / 155
页数:9
相关论文
共 50 条
  • [21] METABOLISM OF N-6 AND N-3 FATTY-ACIDS IN MAN AND ANIMALS
    GARTON, GA
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1990, 18 (05) : 755 - 756
  • [22] Interplay between n-6 and n-3 fatty acids and cardiovascular risk
    Galli, C.
    Rise, P.
    Marangoni, F.
    Visioli, F.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 472 - 472
  • [23] Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease
    Harbige, LS
    PROCEEDINGS OF THE NUTRITION SOCIETY, 1998, 57 (04) : 555 - 562
  • [24] BIOCHEMICAL DIFFERENCES BETWEEN N-3 AND N-6 FATTY-ACIDS
    LANDS, WEM
    HEALTH EFFECTS OF FISH AND FISH OILS, 1989, : 9 - 21
  • [25] n-3 versus n-6 polyunsaturated fatty acids in critical illness
    Tashiro, T
    Yamamori, H
    Takagi, K
    Hayashi, N
    Furukawa, K
    Nakajima, N
    NUTRITION, 1998, 14 (06) : 551 - 553
  • [26] Modulation of endothelial dysfunction by n-3 versus n-6 fatty acids
    Cherki, M.
    Isabelle, M.
    Macaire, J-P.
    Tricot, S.
    Gueugneau, A-M.
    Adlouni, A.
    Khalil, A.
    Christon, R.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2006, 143 (1-2) : 91 - 92
  • [27] The role of dietary n-6 and n-3 fatty acids in the developing brain
    Innis, SM
    DEVELOPMENTAL NEUROSCIENCE, 2000, 22 (5-6) : 474 - 480
  • [28] Relationship between the n-6/n-3 Ratio in Dietary Fatty Acids and the n-6/n-3 Ratio in Blood Fatty Acids or Whole Blood Aggregation in Young Adult Women
    Eto, Y.
    Sato, Y.
    Tamura, A.
    Nippon Eiyo Shokuryo Gakkaishi/Japanese Society of Nutrition and Food Science, Journal, 1996, 49 (03):
  • [29] Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction
    Chiusolo, Simona
    Bork, Christian Sorensen
    Gentile, Francesco
    Lundbye-Christensen, Soren
    Harris, William S.
    Schmidt, Erik Berg
    De Caterina, Raffaele
    AMERICAN HEART JOURNAL, 2023, 262 : 38 - 48
  • [30] Interactions between n-3 and n-6 polyunsaturated fatty acids in brain of n-3 deficient rats
    Contreras, MA
    Rapoport, SI
    JOURNAL OF NEUROCHEMISTRY, 2003, 87 : 9 - 9